rosiglitazone has been researched along with Congestive Ophthalmopathy in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonelli, A; Fallahi, P; Ferrannini, E; Ferrari, SM; Franceschini, SS; Frascerra, S; Santini, E | 1 |
Antonelli, A; Bernini, G; Fallahi, P; Ferrannini, E; Ferrari, SM; Frascerra, S; Gelmini, S; Pupilli, C; Ruffilli, I; Sellari-Franceschini, S | 1 |
Antonelli, A; Fallahi, P; Ferrannini, E; Ferrari, SM; Franceschini, SS; Romagnani, P; Rotondi, M; Serio, M | 1 |
Goldberg, RA; Lee, S; McCann, JD; Tsirbas, A | 1 |
Aberg, M; Asman, P; de Capretz, A; Frenander, C; Groop, L; Hallengren, B; Lantz, M; Parikh, H; Vondrichova, T | 1 |
5 other study(ies) available for rosiglitazone and Congestive Ophthalmopathy
Article | Year |
---|---|
Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Topics: Adipocytes; Cells, Cultured; Chemokine CXCL11; Chemokine CXCL9; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Graves Disease; Graves Ophthalmopathy; Humans; Hypoglycemic Agents; Interferon-gamma; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones; Thyroid Gland; Tumor Necrosis Factor-alpha | 2009 |
β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy.
Topics: Cells, Cultured; Chemokine CCL2; Chemokine CXCL10; Fenofibrate; Fibroblasts; Graves Ophthalmopathy; Humans; Interferon-gamma; Pioglitazone; PPAR alpha; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2012 |
Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
Topics: Adult; Cell Differentiation; Chemokine CXCL10; Chemokines, CXC; Female; Fibrinolytic Agents; Graves Ophthalmopathy; Humans; Interferon-gamma; Lymphocyte Activation; Male; PPAR gamma; Rosiglitazone; T-Lymphocytes; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2006 |
Thiazolidinedione induced thyroid associated orbitopathy.
Topics: Diplopia; Disease Progression; Drug Therapy, Combination; Exophthalmos; Female; Graves Ophthalmopathy; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Metformin; Middle Aged; Propranolol; Propylthiouracil; Retreatment; Rosiglitazone; Thiazolidinediones | 2007 |
COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy.
Topics: Adipocytes; Adipogenesis; Cell Differentiation; Cyclooxygenase 2; Dexamethasone; Diclofenac; Gene Expression; Graves Ophthalmopathy; Humans; Insulin; Rosiglitazone; Stearoyl-CoA Desaturase; Thiazolidinediones | 2007 |